Entrada Therapeutics Inc
TRDA5.920USD
+0.120+2.07%
收盘 08/04, 16:00（美东）报价延迟15分钟
5.920USD+5.920盘后交易 (美东)
224.62M总市值
9.06市盈率 TTM
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2020Q4
FY2020Q3
营业总收入
-65.23%20.56M
-10.63%37.40M
-55.25%19.57M
421.16%94.69M
134.05%59.12M
--41.85M
--43.73M
--18.17M
--25.26M
----
----
----
----
----
----
----
----
营业收入
-65.23%20.56M
-10.63%37.40M
-55.25%19.57M
421.16%94.69M
134.05%59.12M
--41.85M
--43.73M
--18.17M
--25.26M
----
----
----
----
----
----
----
----
营业费用
11.42%42.35M
17.11%43.27M
38.71%41.23M
19.73%41.27M
22.45%38.01M
44.43%36.94M
14.60%29.72M
46.17%34.47M
40.13%31.04M
38.56%25.58M
80.56%25.94M
--23.58M
--22.15M
113.34%18.46M
105.99%14.36M
--8.65M
--6.97M
研发费用
12.12%32.07M
18.08%33.41M
40.85%31.26M
21.81%32.03M
23.83%28.61M
80.37%28.29M
17.05%22.19M
61.87%26.30M
46.98%23.10M
26.88%15.69M
80.33%18.96M
--16.25M
--15.72M
85.73%12.36M
84.44%10.51M
--6.66M
--5.70M
折旧摊销及损耗
1.28%946.00K
35.87%1.00M
12.35%937.00K
24.66%910.00K
72.64%934.00K
40.19%736.00K
62.26%834.00K
46.00%730.00K
35.25%541.00K
44.23%525.00K
70.20%514.00K
--500.00K
--400.00K
264.00%364.00K
202.00%302.00K
--100.00K
--100.00K
营业利润
-203.21%-21.79M
-219.61%-5.87M
-254.57%-21.66M
427.77%53.42M
465.28%21.11M
119.18%4.91M
154.03%14.01M
30.88%-16.30M
73.91%-5.78M
-38.56%-25.58M
-80.56%-25.94M
---23.58M
---22.15M
-113.34%-18.46M
-105.99%-14.36M
---8.65M
---6.97M
净非营业利息收入（费用）
其他非经营性收入（费用）
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
税前利润
-168.50%-17.35M
-108.04%-739.00K
-187.98%-15.89M
578.35%57.79M
910.98%25.33M
137.34%9.20M
171.86%18.06M
47.88%-12.08M
85.59%-3.12M
-33.51%-24.63M
-74.20%-25.14M
---23.18M
---21.67M
-112.69%-18.45M
-106.44%-14.43M
---8.67M
---6.99M
所得税
-100.00%0.00
-109.98%-1.87M
89.31%-1.86M
-80.08%2.76M
-48.44%1.83M
--18.74M
---17.40M
--13.85M
--3.55M
----
----
----
----
----
----
----
----
除税后利润
-173.84%-17.35M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.50M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-33.51%-24.63M
-74.20%-25.14M
---23.18M
---21.67M
-112.69%-18.45M
-106.44%-14.43M
---8.67M
---6.99M
持续经营利润
-173.84%-17.35M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.50M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-33.51%-24.63M
-74.20%-25.14M
---23.18M
---21.67M
-112.69%-18.45M
-106.44%-14.43M
---8.67M
---6.99M
归属于母公司的净利润
-173.84%-17.35M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.50M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-33.51%-24.63M
-74.20%-25.14M
---23.18M
---21.67M
-112.69%-18.45M
-106.44%-14.43M
---8.67M
---6.99M
归属于普通股东的净利润
-173.84%-17.35M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.50M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-33.51%-24.63M
-74.20%-25.14M
---23.18M
---21.67M
-112.69%-18.45M
-106.44%-14.43M
---8.67M
---6.99M
基本每股收益
-160.22%-0.42
109.68%0.03
-132.41%-0.35
305.93%1.61
440.25%0.70
63.59%-0.29
232.66%1.07
-5.49%-0.78
70.28%-0.21
73.31%-0.79
-66.35%-0.80
---0.74
---0.69
-914.21%-2.94
-106.43%-0.48
---0.29
---0.23
稀释每股收益
-162.54%-0.42
109.14%0.03
-133.87%-0.35
298.23%1.55
427.60%0.68
63.59%-0.29
226.96%1.02
-5.49%-0.78
70.28%-0.21
73.31%-0.79
-66.35%-0.80
---0.74
---0.69
-914.21%-2.94
-106.43%-0.48
---0.29
---0.23
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
货币单位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
审计意见
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
